Therapeutic Delivery – News and Features

According to Amy Parkhurst, a doctoral candidate at the University of California, Davis, micro- and nanoplastics could be damaging our livers and increasing our chances of developing glucose intolerance.

A protein that gives fleas their bounce has been used to boot out bacteria cells, with lab results demonstrating the material’s potential for preventing medical implant infection.

A new method for targeted drug delivery uses chemically tagged platelets, offering fast, efficient treatment with minimal long-term drug presence.

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming next in cardiac care.

A new material developed at Cornell could significantly improve the delivery and effectiveness of mRNA vaccines – used to fight COVID-19 – by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.

Taken together, rapamycin and trametinib were found to extend the lifespan of mice by around 30 percent and work better than either of the drugs alone.

The Blood In situ Tracking (SENSBIT) system remained fully functional for up to a week when implanted directly into the blood vessels of live rats.

Scientists have engineered a new type of sensor to monitor substances in the body over long stretches – measuring reactions for up to a week after being implanted in living rats.

Researchers have developed a new gene therapy that can be delivered using a nasal spray, ensuring that the therapeutic is efficiently delivered to where it is needed in the lungs and airway.

Scientists demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the layers and orientation of the constituent molecules. This method could be used to help improve drug delivery.